Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D

Table 1 Baseline characteristics of the study patients

No. of patients	233
Male:female	192:41
Age (yr)	42 (16-69)
BMI (kg/m2)	23.4 (14.3-40)
Ascites	50 (21.5)
Encephalopathy	15 (6.4)
Bilirubin (mg/dL)	0.90 (0.2-6.9)
Albumin (g/dL)	3.8 (1.8-5.0)
INR	1.13 (0.6-2.6)
Creatinine (mg/dL)	0.8 (0.4-1.96)
Sodium (mmol/L)	139 (120-150)
AST (IU/L)	53 (10-638)
Platelets (× 109/L)	120 (22-388)
Cholinesterase (IU/L)	5508 (861-12891)
Child class
A	167 (71.7)
B	52 (22.3)
C	14 (5.0)
CTP score	5 (5-13)
MELD score	8 (6-24)
MELD sodium	9 (6-26)
MELD score 15 or more	24 (10.3)
APRI	1.26 (0.19-10.8)
APRI 1.5 or more	100 (42.9)
BEA class
A	6 (2.6)
B	164 (70.4)
C	63 (27)
BEA score	4 (1-7)

Values are median (range) or n (%). BMI: Body mass index; INR: International normalization ratio; AST: Aspartate aminotransferase; CTP: Child Turgotte Pugh; MELD: Model for End Stage Liver Disease; APRI: AST to platelet ratio index; BEA: Baseline-event-anticipation.